EP Biocomposites quarterly results and financials

EP Biocomposites (BSE 543595)₹87.00−3.12%(9 Nov 2026 close)Waste Management

Key facts

In the Mar 2026 quarter (standalone), EP Biocomposites reported sales of ₹9.60 Cr, up 25.8% from Mar 2025, and net profit of ₹1.36 Cr, up 65.9% year on year. For the year to Mar 2026, sales were ₹13.69 Cr and net profit ₹1.45 Cr.

Sales (Mar 2026): ₹9.60 Cr
Net profit (Mar 2026): ₹1.36 Cr
Sales (FY Mar 2026): ₹13.69 Cr
Net profit (FY Mar 2026): ₹1.45 Cr
EPS (Mar 2026): ₹8.12
Borrowings (Mar 2026): ₹2.39 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

EP Biocomposites quarterly results

₹ crore unless stated; each column is a quarter.

EP Biocomposites Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	3.69	4.41	7.06	4.41	7.63	4.08	9.60
Expenses	3.25	4.13	5.89	3.90	6.30	3.81	7.56
Operating Profit	0.43	0.27	1.15	0.50	1.30	0.26	2.00
OPM %	11.4%	5.9%	16.3%	11.2%	17.0%	6.2%	20.8%
Other Income	0.12	0.08	0.20	0.04	0.05	0.06	0.06
Interest	0.06	0.02	0.01	0.18	0.20	0.14	0.20
Depreciation	0.06	0.06	0.06	0.06	0.07	0.06	0.06
Profit before tax	0.44	0.28	1.27	0.31	1.09	0.11	1.81
Tax %	33.3%	27.6%	27.3%	34.4%	25.4%	33.3%	24.7%
Net Profit	0.29	0.21	0.92	0.20	0.82	0.08	1.36
EPS (Rs)	1.77	1.30	5.51	1.24	4.93	0.53	8.12

EP Biocomposites profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

EP Biocomposites Profit and loss
	Mar 2020 3m	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	0.58	2.96	8.08	7.14	11.47	12.05	13.69
Expenses	0.52	2.48	6.64	6.14	10.00	10.21	11.37
Operating Profit	0.05	0.47	1.41	0.98	1.42	1.79	2.25
OPM %	7.0%	15.7%	17.4%	13.6%	12.4%	14.9%	16.5%
Other Income	0.00	0.00	0.01	0.16	0.29	0.10	0.13
Interest	0.00	0.00	0.20	0.24	0.03	0.37	0.35
Depreciation	0.00	0.00	0.08	0.11	0.11	0.12	0.11
Profit before tax	0.03	0.45	1.15	0.80	1.56	1.41	1.93
Tax %	25.0%	23.9%	31.0%	28.3%	26.7%	27.4%	24.7%
Net Profit	0.02	0.35	0.80	0.57	1.14	1.02	1.45
EPS (Rs)	5.98	71.82	6.86	3.44	6.82	6.11	8.65
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

EP Biocomposites balance sheet

₹ crore, at each year end.

EP Biocomposites Balance sheet
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.04	0.04	1.17	1.67	1.67	1.67	1.67
Reserves	−0.01	0.33	0.81	6.72	7.86	8.90	10.34
Borrowings	0.00	0.00	4.10	1.27	1.79	2.97	2.39
Other Liabilities	0.51	0.95	3.17	2.04	3.74	3.08	4.30
Total Liabilities	0.54	1.32	9.25	11.70	15.06	16.62	18.70
Fixed Assets	0.00	0.00	0.40	0.32	0.32	0.22	0.22
CWIP	0.00	0.00	0.00	0.00	0.15	0.15	0.63
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.54	1.32	8.85	11.38	14.59	16.25	17.85
Inventories	0.12	0.46	1.19	1.03	1.04	1.42	1.35
Trade receivables	0.31	0.66	7.11	5.87	9.02	10.87	11.85
Cash & equivalents	0.11	0.14	0.15	2.18	1.26	1.61	2.14
Total Assets	0.54	1.32	9.25	11.70	15.06	16.62	18.70

EP Biocomposites cash flow

₹ crore, for each year.

EP Biocomposites Cash flow
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.11	0.02	−4.27	−0.78	−1.23	−0.48	1.98
Cash from investing activity	0.00	0.00	−0.48	0.03	−0.17	0.03	−0.54
Cash from financing activity	0.00	0.00	4.78	2.82	0.50	0.83	−0.93
Net cash flow	0.13	0.04	0.02	2.05	−0.93	0.36	0.55
Capex	0.00	0.00	0.48	0.03	0.11	0.03	0.11
Free cash flow	0.13	0.04	−4.76	−0.82	−1.49	−0.51	1.42
CFO / OP %	299.9%	9.0%	−294.1%	−44.1%	−59.1%	−1.0%	104.9%

EP Biocomposites ratios

Working-capital days and returns, by year.

EP Biocomposites Ratios
	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	191	79	321	299	286	329	316
Inventory days	85	91	88	92	51	68	58
Days payable	350	128	162	105	143	98	114
Cash conversion cycle	−74	42	246	286	194	299	260
Working capital days	−59	25	156	255	216	270	237
ROCE %	—	219.0%	41.5%	13.1%	15.3%	14.2%	16.2%

EP Biocomposites: frequently asked questions

What are the latest quarterly results of EP Biocomposites?

For the Mar 2026 quarter, EP Biocomposites reported sales of ₹9.60 Cr, up 25.8% year on year and net profit of ₹1.36 Cr, up 65.9% year on year. The operating margin was 20.8%.

What is the annual revenue of EP Biocomposites?

EP Biocomposites' sales for the year to Mar 2026 were ₹13.69 Cr.

What is the net profit of EP Biocomposites?

Net profit for the year to Mar 2026 was ₹1.45 Cr. Earnings per share over the same trailing period were ₹8.65.

How much debt does EP Biocomposites have?

EP Biocomposites reported borrowings of ₹2.39 Cr at Mar 2026, against cash and equivalents of ₹2.14 Cr.

What is the free cash flow of EP Biocomposites?

Cash from operations was ₹1.98 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.42 Cr.

Loading…